HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alpha-thalassemia phenotype induced by the new IVS-II-2 (T --> A) splice donor site mutation on the alpha2-globin gene.

Abstract
We present a family of North European extraction referred for a refractory non iron depleted microcytic anemia. The proband, a 36 year-old male, presented with chronic borderline anemia and microcytic hypochromic parameters. No abnormal hemoglobin (Hb) fractions were observed on high performance liquid chromatography (HPLC) or on alkaline electrophoresis. Gap-polymerase chain reaction (gap-PCR) excluded the seven common alpha-thalassemia (thal) deletion defects. However, the beta/alpha-globin chain synthesis ratio measured in vitro was unbalanced, indicating a reduced expression of the alpha-globin genes. Direct sequencing of the alpha-globin genes revealed heterozygosity for a T --> A transversion at the IVS-II-2 position of the alpha2 gene. This is the first IVS-II splice donor site mutation described on the alpha2-globin gene.
AuthorsCornelis L Harteveld, Max C W Jebbink, Nico van der Lely, Peter van Delft, Nicole Akkermans, Sandra Arkesteyn, Piero C Giordano
JournalHemoglobin (Hemoglobin) Vol. 30 Issue 1 Pg. 3-7 ( 2006) ISSN: 0363-0269 [Print] England
PMID16540408 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Hemoglobins
  • Protein Subunits
  • Globins
Topics
  • Adult
  • Alleles
  • Alternative Splicing
  • Anemia, Hypochromic (blood, genetics)
  • Chronic Disease
  • DNA Mutational Analysis
  • Family Health
  • Gene Deletion
  • Globins (genetics)
  • Hemoglobins (genetics)
  • Humans
  • Male
  • Pedigree
  • Phenotype
  • Point Mutation
  • Protein Subunits (genetics)
  • alpha-Thalassemia (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: